About
Savara is a clinical-stage biopharmaceutical company developing inhaled therapies for rare respiratory diseases, including autoimmune pulmonary alveolar proteinosis and other rare pulmonology conditions.
Explore Savara's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.